Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide therapy

Ähnliche Einträge

• Exercise in newly diagnosed patients with multiple myeloma: A randomized controlled trial of effects on physical function, physical activity, lean body mass, bone mineral density, pain, and quality of life
  von: Rikke F. Larsen, et al.
  Veröffentlicht: (2024)
• Twice‐weekly induction with ixazomib–lenalidomide–dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant‐eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014‐03
  von: Aurore Perrot, et al.
  Veröffentlicht: (2024)
• Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations
  von: Gayathri Ravi, et al.
  Veröffentlicht: (2024)
• Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real‐world: The retrospective IMAGE study
  von: Olivier Decaux, et al.
  Veröffentlicht: (2024)
• The EASEMENT study: A multicentre, observational, cross‐sectional study to evaluate patient preferences, treatment satisfaction, quality of life, and healthcare resource use in patients with multiple myeloma receiving injectable‐containing or fully oral therapies
  von: Robert Ayto, et al.
  Veröffentlicht: (2024)